Learn
About Us

More

Featured Content

Latest Press Releases

See All Press Releases

Statements

Our Commitment to Anti-Racism
Our Commitment to Pay Equity

Named Patient Use Programs

Named Patient Use Program for TEPEZZA® (teprotumumab-trbw)
Named Patient Use Program for UPLIZNA® (inebilizumab-cdon)

Featured Videos

See All Videos

Corporate Brochure

Corporate Brochure

Fact Sheets & Downloads

See All Fact Sheets

Logo Download

Horizon Logo | Full Color
Horizon Logo | Full Color, White Text
Horizon Logo | White
Horizon Logo | Charcoal

If you are looking for additional Horizon media assets, please contact corpcomms@horizontherapeutics.com.

Media Inquiries

For U.S. media inquiries, contact:
Geoff Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com
+1 (888) 506-2562

For EU media inquiries, contact:
Ray Gordon
Managing Director
ray@gordonmrm.ie
+353 (87) 2417373